These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4730826)

  • 41. Effects of chronic exposure to delta9-tetrahydrocannabinol on delayed matching-to-sample in chimpanzees.
    Ferraro DP; Grilly DM
    Psychopharmacologia; 1974 Jun; 37(4):127-38. PubMed ID: 4844118
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of normal growth by chronic administration of delta-9-tetrahydrocannabinol.
    Manning FJ; McDonough JH; Elsmore TF; Saller C; Sodetz FJ
    Science; 1971 Oct; 174(4007):424-6. PubMed ID: 5111999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analgesic, heart rate, and temperature effects of delta8-THC during acute and chronic administration to conscious rats.
    Hine B; Toreelio M; Gershon S
    Pharmacology; 1977; 15(1):63-72. PubMed ID: 14347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute tolerance to the effects of delta-9-tetrahydrocannabinol on spaced responding by monkeys.
    Manning FJ
    Pharmacol Biochem Behav; 1973; 1(6):665-71. PubMed ID: 4206609
    [No Abstract]   [Full Text] [Related]  

  • 45. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of oral delta9-tetrahydrocannabinol on operant reinforcement schedule performance in rats.
    Ferraro DP; Gluck JP
    Pharmacology; 1974; 11(2):65-9. PubMed ID: 4829291
    [No Abstract]   [Full Text] [Related]  

  • 47. Delta-9-tetrahydrocannabinol and glucose tolerance.
    Hollister LE; Reaven GM
    Clin Pharmacol Ther; 1974 Aug; 16(2):297-302. PubMed ID: 4851289
    [No Abstract]   [Full Text] [Related]  

  • 48. Acquisition and loss of tolerance to 1- 9 -trans-tetrahydrocannabinol in rats on an avoidance schedule.
    Webster CD; LeBlanc AE; Marshman JA; Beaton JM
    Psychopharmacologia; 1973 Jun; 30(3):217-26. PubMed ID: 4716617
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of varying doses of delta 9-tetrahydrocannabinol on the human visual and somatosensory evoked response.
    Lewis EG; Dustman RE; Peters B; Straight RC; Beck EC
    Electroencephalogr Clin Neurophysiol; 1973 Oct; 35(4):347-54. PubMed ID: 4126806
    [No Abstract]   [Full Text] [Related]  

  • 50. Cannabis-induced hypothermia: a dose-effect comparison of crude marihuana extract and synthetic 9 -tetrahydrocannabinol in male and female rats.
    Borgen LA; Lott GC; Davis WM
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):621-6. PubMed ID: 4701259
    [No Abstract]   [Full Text] [Related]  

  • 51. Modification of the effects of 9 -tetrahydrocannabinol by phenobarbital pretreatment in mice.
    Fujimoto JM
    Toxicol Appl Pharmacol; 1972 Dec; 23(4):623-34. PubMed ID: 4644697
    [No Abstract]   [Full Text] [Related]  

  • 52. Blood levels of 3 H- 9 -tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons.
    McMillan DE; Dewey WL; Turk RF; Harris LS; McNeil JH
    Biochem Pharmacol; 1973 Feb; 22(3):383-97. PubMed ID: 4687134
    [No Abstract]   [Full Text] [Related]  

  • 53. 9 -Tetrahydrocannabinol effect on audiogenic seizure susceptibility.
    Boggan WO; Steele RA; Freedman DX
    Psychopharmacologia; 1973 Mar; 29(2):101-6. PubMed ID: 4709834
    [No Abstract]   [Full Text] [Related]  

  • 54. [Subjective changes with delta 9 trans-tetrahydrocannabinol in cannabis naive subjects].
    Dittrich A; Woggon B
    Int Pharmacopsychiatry; 1974; 9(3):138-51. PubMed ID: 4609941
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 56. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
    Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
    Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Some pharmacological effects of phenitrone and its interaction with 9 -THC.
    Spaulding TC; Ford RD; Dewey WL; McMillan DE; Harris LS
    Eur J Pharmacol; 1972 Sep; 19(3):310-7. PubMed ID: 4640854
    [No Abstract]   [Full Text] [Related]  

  • 58. Depth perception in rats following acute or chronic injections of D1- 9 tetrahydrocannabinol.
    Fried PA; Husband CA
    Life Sci I; 1973 Apr; 12(7):289-95. PubMed ID: 4695123
    [No Abstract]   [Full Text] [Related]  

  • 59. Cannabidiol interaction with delta9-tetrahydrocannabinol.
    Borgen LA; Davis WM
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):663-70. PubMed ID: 4828762
    [No Abstract]   [Full Text] [Related]  

  • 60. Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.
    Hayakawa K; Mishima K; Nozako M; Ogata A; Hazekawa M; Liu AX; Fujioka M; Abe K; Hasebe N; Egashira N; Iwasaki K; Fujiwara M
    Neuropharmacology; 2007 Mar; 52(4):1079-87. PubMed ID: 17320118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.